Skip to main content
SpringerLink
Log in

La tomographie d’émission de positons au 18F-FDG ou TEP-scan et les métastases vertébrales

  • Chapter
Métastases vertébrales

  • 376 Accesses

Abstrait

La tomographie d’émission de positons (TEP-scan ou PET-scan en littérature anglo-saxonne) est une technique d’imagerie métabolique et fonctionnelle utilisée en France pour l’instant uniquement en cancérologie. C’est désormais une méthode de choix pour le bilan préthérapeutique de nombreuses pathologies oncologiques, en particulier les cancers du poumon, des VADS (voies aérodigestives supérieures), de l’œsophage, les cancers colorectaux et les lymphomes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Abe K, Sasaki M, Kuwabara Y, Koga H, Baba S, Hayashi K, Takahashi N, Honda H (2005) Comparison of 18FDG-PET with 99mTc-HMDP scintigraphy for the detection of bone metastases in patients with breast cancer. Ann Nucl Med 19: 573–9

    PubMed  Google Scholar 

  2. Abouzied MM, Crawford ES, Nabi HA (2005) 18F-FDG Imaging: pitfalls and artifacts. J Nucl Med Technol 33: 145–55

    PubMed  Google Scholar 

  3. Aflalo-Hazan V, Gutman F, Raileanu I, Fretault J, Kerrou K, Grahek D, Montravers F, Talbot JN (2006) TEP au 18F-FDG et scintigraphie du squelette dans la recherche de métastases osseuses du cancer broncho-pulmonaire. Rev Pneumol Clin 62: 164–9

    PubMed  CAS  Google Scholar 

  4. Basu S, Nair N (2006) “Cold” Vertebrae on F-18 FDG PET: causes and characteristics. Clin Nucl Med 31: 445–50

    Article  PubMed  Google Scholar 

  5. Beaulieu S, Rubin B, Djang D, Conrad E, Turcotte E, Eary JF (2004) Positron emission tomography of schwannomas: emphasizing its potential in preoperative planning. AJR Am J Roentgenol 182: 971–4

    PubMed  Google Scholar 

  6. Bohdiewicz PJ, Wong CY, Kondas D, Gaskill M, Dworkin HJ (2003) High predictive value of F-18 FDG PET patterns of the spine for metastases or benign lesions with good agreement between readers. Clin Nucl Med 28: 966–70

    Article  PubMed  Google Scholar 

  7. Bourguet P et le Groupe de travail SOR (2003) Recommandations pour la pratique clinique: Standards, Options et Recommandations 2003 pour l’utilisation de la tomographie par émission de positons au 18F-FDG (TEP-FDG) en cancérologie (rapport intégral). Fédération Nationale des Centres de Lutte contre le Cancer, Paris. Available from URL: http://www.fnclcc.fr/sor/SORSpecialistes/EvaluationTechno/Nucleaire/Util-TEP-FDG/fiche.html

    Google Scholar 

  8. Bourguet P et le Groupe de travail SOR (2005) Comprendre la TEP: Tomographie par émission de positons au 18F-FDG en cancérologie. Guide d’information et de dialogue à l’usage des personnes malades et de leurs proches (Standards, Options et Recommandations SAVOIR). Fédération Nationale des Centres de Lutte contre le Cancer, Paris. Available from URL: http://www.fnclcc.fr/sor/SSP/EvaluationTechno/Nucleaire/Util-TEP-FDG/fiche.html

    Google Scholar 

  9. Bourguet P, Hitzel A, Houvenaeghel G, Vinatier D, Bosquet L, Bonichon F, Corone C, Giard-Lefèvre S, Morett JL, Touboul E (2006) Recommandations pour la pratique clinique: utilisation de la TEP-FDG dans les cancers du sein, de l’ovaire et de l’utérus. Bull Cancer 93: 385–90

    PubMed  CAS  Google Scholar 

  10. Bredella MA, Steinbach L, Caputo G, Segall G, Hawkins R (2005) Value of FDG PET in the assessment of patients with multiple myeloma. AJR Am J Roentgenol 184: 1199–204

    PubMed  Google Scholar 

  11. Bury T, Barreto A, Daenen F, Barthelemy N, Ghaye B, Rigo P (1998) Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer. Eur J Nucl Med 25: 1244–7

    Article  PubMed  CAS  Google Scholar 

  12. Carr R, Barrington SF, Madan B, O’Doherty MJ, Saunders CA, van der Walt J, Timothy AR (1998) Detection of lymphoma in bone marrow by whole-body positron emission tomography. Blood 91: 3340–6

    PubMed  CAS  Google Scholar 

  13. Cheran SK, Herndon JE, Patz EF Jr (2004) Comparison of whole-body FDG-PET to bone scan for detection of bone metastases in patients with a new diagnosis of lung cancer. Lung Cancer 44: 317–25

    Article  PubMed  Google Scholar 

  14. Cook GJ, Houston S, Rubens R, Maisey MN, Fogelman I (1998) Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions. J Clin Oncol 16: 3375–9

    PubMed  CAS  Google Scholar 

  15. Cook GJ, Maisey MN, Fogelman I (1997) Fluorine-18-FDG PET in Paget’s disease of bone. J Nucl Med 38: 1495–7

    PubMed  CAS  Google Scholar 

  16. Cook GJ, Wegner EA, Fogelman I (2004) Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging. Semin Nucl Med 34: 122–33

    Article  PubMed  Google Scholar 

  17. Cook GJR (2006) PET imaging of the skeleton. In: Valk PE, Delbeke D, Bailey DL, Townsend DW, Maisey MN (eds) Positron emission tomography: clinical practice. Springer, London, p 317

    Chapter  Google Scholar 

  18. Crymes WB Jr, Demos H, Gordon L (2004) Detection of musculoskeletal infection with 18F-FDG PET: review of the current literature. J Nucl Med Technol 32: 12–5

    PubMed  Google Scholar 

  19. Daldrup-Link HE, Franzius C, Link TM, Laukamp D, Sciuk J, Jurgens H, Schober O, Rummeny EJ (2001) Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET. AJR Am J Roentgenol 177: 229–36

    PubMed  CAS  Google Scholar 

  20. Delbeke D (2006) Incremental value of imaging structure and function. In: Valk PE, Delbeke D, Bailey DL, Townsend DW, Maisey MN (eds) Positron emission tomography: clinical practice. Springer, London, p 17

    Chapter  Google Scholar 

  21. Delbeke D, Coleman RE, Guiberteau MJ, Brown ML, Royal HD, Siegel BA, Townsend DW, Berland LL, Parker JA, Hubner K, Stabin MG, Zubal G, Kachelriess M, Cronin V, Holbrook S (2006) Procedure Guideline for Tumor Imaging with 18F-FDG PET/CT 1.0. J Nucl Med 47: 885–95

    PubMed  Google Scholar 

  22. Dose J, Bleckmann C, Bachmann S, Bohuslavizki KH, Berger J, Jenicke L, Habermann CR, Janicke F (2002) Comparison of fluorodeoxyglucose positron emission tomography and “conventional diagnostic procedures” for the detection of distant metastases in breast cancer patients. Nucl Med Commun 23: 857–64

    Article  PubMed  CAS  Google Scholar 

  23. Durski JM, Srinivas S, Segall G (2000) Comparison of FDG-PET and Bone Scans for Detecting Skeletal Metastases in Patients with Non-small Cell Lung Cancer. Clin Positron Imaging 3: 97–105

    Article  PubMed  Google Scholar 

  24. Fayad LM, Cohade C, Wahl RL, Fishman EK (2003) Sacral fractures: a potential pitfall of FDG positron emission tomography. AJR Am J Roentgenol 181: 1239–43

    PubMed  Google Scholar 

  25. Gallowitsch HJ, Kresnik E, Gasser J, Kumnig G, Igerc I, Mikosch P, Lind P (2003) F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging. Invest Radiol 38: 250–6

    Article  PubMed  Google Scholar 

  26. Gambhir SS, Czernin J, Schwimmer J, Silverman DH, Coleman RE, Phelps ME (2001) A tabulated summary of the FDG PET literature. J Nucl Med 42: 1S–93S

    PubMed  CAS  Google Scholar 

  27. Garcia JR, Simo M, Perez G, Soler M, Lopez S, Setoain X, Lomena F (2003) 99mTc-MDP bone scintigraphy and 18F-FDG positron emission tomography in lung and prostate cancer patients: different affinity between lytic and sclerotic bone metastases. Eur J Nucl Med Mol Imaging 30: 1714

    Article  PubMed  CAS  Google Scholar 

  28. Gayed I, Vu T, Johnson M, Macapinlac H, Podoloff D (2003) Comparison of bone and 2-deoxy-2-(18F)fluoro-D-glucose positron emission tomography in the evaluation of bony metastases in lung cancer. Mol Imaging Biol 5: 26–31

    Article  PubMed  Google Scholar 

  29. Ghanem N, Uhl M, Brink I, Schafer O, Kelly T, Moser E, Langer M (2005) Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for the detection of metastases of bone. Eur J Radiol 55: 41–55

    Article  PubMed  CAS  Google Scholar 

  30. Hany TF, Gharehpapagh E, Kamel EM, Buck A, Himms-Hagen J, von Schulthess GK (2002) Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region. Eur J Nucl Med Mol Imaging 29: 1393–8

    Article  PubMed  Google Scholar 

  31. Haute Autorité de Santé (HAS) (2006) Évaluation et état des lieux de la tomographie d’émission de positons couplée à la tomodensitométrie (TEP-TDM). Avalaible on: http://www.has-sante.fr

  32. Hsia TC, Shen YY, Yen RF, Kao CH, Changlai SP (2002) Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with non-small cell lung cancer. Neoplasma 49: 267–71

    PubMed  CAS  Google Scholar 

  33. Isasi CR, Moadel RM, Blaufox MD (2005) A meta-analysis of FDG-PET for the evaluation of breast cancer recurrence and metastases. Breast Cancer Res Treat 90: 105–12

    Article  PubMed  CAS  Google Scholar 

  34. Israel O, Goldberg A, Nachtigal A, Militianu D, Bar-Shalom R, Keidar Z, Fogelman I (2006) FDG-PET and CT patterns of bone metastases and their relationship to previously administered anti-cancer therapy. Eur J Nucl Med Mol Imaging 33: 1280–4

    Article  PubMed  Google Scholar 

  35. Jackson RS, Schlarman TC, Hubble WL, Osman MM (2006) Prevalence and Patterns of Physiologic Muscle Uptake Detected with Whole-Body 18F-FDG PET. J Nucl Med Technol 34: 29–33

    PubMed  Google Scholar 

  36. Jadvar H, Conti PS (2002) Diagnostic utility of FDG PET in multiple myeloma. Skeletal Radiol 31: 690–4

    Article  PubMed  Google Scholar 

  37. Jaffe CC (2006) Measures of response: RECIST, WHO, and new alternatives. J Clin Oncol 24: 3245–51

    Article  PubMed  Google Scholar 

  38. Johnston KL, Farnen JP, Manske BR, Go RS (2005) Abnormal positron emission tomography (PET) scan secondary to the use of hematopoietic growth factors. Haematologica 90: EIM03

    PubMed  Google Scholar 

  39. Kalicke T, Schmitz A, Risse JH, Arens S, Keller E, Hansis M, Schmitt O, Biersack HJ, Grunwald F (2000) Fluorine-18 fluorodeoxyglucose PET in infectious bone diseases: results of histologically confirmed cases. Eur J Nucl Med 27: 524–8

    Article  PubMed  CAS  Google Scholar 

  40. Kao CH, Hsieh JF, Tsai SC, Ho YJ, Yen RF (2000) Comparison and discrepancy of 18F-2-deoxyglucose positron emission tomography and Tc-99m MDP bone scan to detect bone metastases. Anticancer Res 20: 2189–92

    PubMed  CAS  Google Scholar 

  41. Kato H, Miyazaki T, Nakajima M, Takita J, Kimura H, Faried A, Sohda M, Fukai Y, Masuda N, Fukuchi M, Manda R, Ojima H, Tsukada K, Kuwano H, Oriuchi N, Endo K (2005) Comparison between whole-body positron emission tomography and bone scintigraphy in evaluating bony metastases of esophageal carcinomas. Anticancer Res 25: 4439–44

    PubMed  Google Scholar 

  42. Kato K, Aoki J, Endo K (2003) Utility of FDG-PET in differential diagnosis of benign and malignant fractures in acute to subacute phase. Ann Nucl Med 17: 41–6

    Article  PubMed  Google Scholar 

  43. Kazama T, Swanston N, Podoloff DA, Macapinlac HA (2005) Effect of colony-stimulating factor and conventional-or high-dose chemotherapy on FDG uptake in bone marrow. Eur J Nucl Med Mol Imaging 32: 1406–11

    Article  PubMed  CAS  Google Scholar 

  44. Kuo PH, Cheng DW (2005) Artifactual Spinal Metastases Imaged by PET/CT: A Case Report. J Nucl Med Technol 33: 230–1

    PubMed  Google Scholar 

  45. Lonneux M, Borbath I, I, Berliere M, Kirkove C, Pauwels S (2000) The place of whole-body PET FDG for the diagnosis of distant recurrence of breast cancer. Clin Positron Imaging 3: 45–9

    Article  PubMed  Google Scholar 

  46. Marom EM, McAdams HP, Erasmus JJ, Goodman PC, Culhane DK, Coleman RE, Herndon JE, Patz EF, Jr. (1999) Staging non-small cell lung cancer with whole-body PET. Radiology 212: 803–9

    PubMed  CAS  Google Scholar 

  47. Maublant J, Vuillez JP, Talbot JN, Lumbroso J, Muratet JP, Herry JY, Artus JC (1998) Tomographie par émission de positons (TEP) et (F-18)-fluorodésoxyglucose (FDG) en cancérologie. Bull Cancer 85: 935–50

    PubMed  CAS  Google Scholar 

  48. Metser U, Lerman H, Blank A, Lievshitz G, Bokstein F, Even-Sapir E (2004) Malignant involvement of the spine: assessment by 18F-FDG PET/CT. J Nucl Med 45: 279–84

    PubMed  Google Scholar 

  49. Minotti AJ, Shah L, Keller K (2004) Positron emission tomography/computed tomography fusion imaging in brown adipose tissue. Clin Nucl Med 29: 5–11

    Article  PubMed  Google Scholar 

  50. Moog F, Bangerter M, Kotzerke J, Guhlmann A, Frickhofen N, Reske SN (1998) 18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow. J Clin Oncol 16: 603–9

    PubMed  CAS  Google Scholar 

  51. Moog F, Kotzerke J, Reske SN (1999) FDG PET can replace bone scintigraphy in primary staging of malignant lymphoma. J Nucl Med 40: 1407–13

    PubMed  CAS  Google Scholar 

  52. Moon DH, Maddahi J, Silverman DH, Glaspy JA, Phelps ME, Hoh CK (1998) Accuracy of whole-body fluorine-(18)FDG PET for the detection of recurrent or metastatic breast carcinoma. J Nucl Med 39: 431–5

    PubMed  CAS  Google Scholar 

  53. Morris MJ, Akhurst T, Osman I, Nunez R, Macapinlac H, Siedlecki K, Verbel D, Schwartz L, Larson SM, Scher HI (2002) Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancer. Urology 59: 913–8

    Article  PubMed  Google Scholar 

  54. Ohta M, Tokuda Y, Suzuki Y, Kubota M, Makuuchi H, Tajima T, Nasu S, Suzuki Y, Yasuda S, Shohtsu A (2001) Whole body PET for the evaluation of bony metastases in patients with breast cancer: comparison with 99Tcm-MDP bone scintigraphy. Nucl Med Commun 22: 875–9

    Article  PubMed  CAS  Google Scholar 

  55. Pakos EE, Fotopoulos AD, Ioannidis JP (2005) 18F-FDG PET for evaluation of bone marrow infiltration in staging of lymphoma: a meta-analysis. J Nucl Med 46: 958–63

    PubMed  Google Scholar 

  56. Pieterman RM, van Putten JW, Meuzelaar JJ, Mooyaart EL, Vaalburg W, Koeter GH, Fidler V, Pruim J, Groen HJ (2000) Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med 343: 254–61

    Article  PubMed  CAS  Google Scholar 

  57. Schirrmeister H, Bommer M, Buck AK, Muller S, Messer P, Bunjes D, Dohner H, Bergmann L, Reske SN (2002) Initial results in the assessment of multiple myeloma using 18F-FDG PET. Eur J Nucl Med Mol Imaging 29: 361–6

    Article  PubMed  CAS  Google Scholar 

  58. Shon IH, Fogelman I (2003) F-18 FDG positron emission tomography and benign fractures. Clin Nucl Med 28: 171–5

    Article  PubMed  Google Scholar 

  59. Shreve PD, Grossman HB, Gross MD, Wahl RL (1996) Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-(F-18)fluoro-D-glucose. Radiology 199: 751–6

    PubMed  CAS  Google Scholar 

  60. Stafford SE, Gralow JR, Schubert EK, Rinn KJ, Dunnwald LK, Livingston RB, Mankoff DA (2002) Use of serial FDG PET to measure the response of bone-dominant breast cancer to therapy. Acad Radiol 9: 913–21

    Article  PubMed  Google Scholar 

  61. Therasse P, Le Cesne A, Van Glabbeke M, Verweij J, Judson I (2005) RECIST vs. WHO: Prospective comparison of response criteria in an EORTC phase II clinical trial investigating ET-743 in advanced soft tissue sarcoma. Eur J Cancer 41: 1426–30

    Article  PubMed  CAS  Google Scholar 

  62. Truong MT, Erasmus JJ, Munden RF, Marom EM, Sabloff BS, Gladish GW, Podoloff DA, Macapinlac HA (2004) Focal FDG uptake in mediastinal brown fat mimicking malignancy: a potential pitfall resolved on PET/CT. AJR Am J Roentgenol 183: 1127–32

    PubMed  Google Scholar 

  63. Tsukamoto E, Ochi S (2006) PET/CT today: system and its impact on cancer diagnosis. Ann Nucl Med 20: 255–67

    PubMed  Google Scholar 

  64. Uematsu T, Yuen S, Yukisawa S, Aramaki T, Morimoto N, Endo M, Furukawa H, Uchida Y, Watanabe J (2005) Comparison of FDG PET and SPECT for detection of bone metastases in breast cancer. AJR Am J Roentgenol 184: 1266–73

    PubMed  Google Scholar 

  65. Wu HC, Yen RF, Shen YY, Kao CH, Lin CC, Lee CC (2002) Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diphosphate bone scan to detect bone metastases in patients with renal cell carcinomas: a preliminary report. J Cancer Res Clin Oncol 128: 503–6

    Article  PubMed  CAS  Google Scholar 

  66. Yang SN, Liang JA, Lin FJ, Kao CH, Lin CC, Lee CC (2002) Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diphosphonate bone scan to detect bone metastases in patients with breast cancer. J Cancer Res Clin Oncol 128: 325–8

    Article  PubMed  CAS  Google Scholar 

  67. Yeh SD, Imbriaco M, Larson SM, Garza D, Zhang JJ, Kalaigian H, Finn RD, Reddy D, Horowitz SM, Goldsmith SJ, Scher HI (1996) Detection of bony metastases of androgen-independent prostate cancer by PET-FDG. Nucl Med Biol 23: 693–7

    Article  PubMed  CAS  Google Scholar 

  68. Yeung HW, Grewal RK, Gonen M, Schoder H, Larson SM (2003) Patterns of 18F-FDG uptake in adipose tissue and muscle: a potential source of false-positives for PET. J Nucl Med 44: 1789–96

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut Bergonié, 229, cours de l’Argonne, 33076, Bordeaux Cedex

    Françoise Bonichon (Médecin cancérologue)

Authors
  1. Françoise Bonichon
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Service de Chirurgie Orthopédique et Réparatrice, Hôpital Pellegrin-Tripode, Place Amélie-Raba-Léon, 33076, Bordeaux Cedex

    Vincent Pointillart

  2. Service d’oncologie médicale, Hôpital Saint-André - CHU Bordeaux, 1, rue Jean Burguet, 33075, Bordeaux Cedex

    Alain Ravaud

  3. Institut Bergonié, 229, cours de l’Argonne, 33076, Bordeaux Cedex

    Jean Palussière

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag France, Paris

About this chapter

Cite this chapter

Bonichon, F. (2007). La tomographie d’émission de positons au 18F-FDG ou TEP-scan et les métastases vertébrales. In: Pointillart, V., Ravaud, A., Palussière, J. (eds) Métastases vertébrales. Springer, Paris. https://doi.org/10.1007/978-2-287-33744-4_8

Download citation

  • DOI: https://doi.org/10.1007/978-2-287-33744-4_8

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-33743-7

  • Online ISBN: 978-2-287-33744-4

Publish with us

Policies and ethics

Search

Navigation